What is "epratuzumab"

n. A humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.

Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE).